Official Title: “Adaptive Brief Interventions for Drop-Out re-Engagement”

We will evaluate a series of interventions intended to help individuals who drop out of substance abuse treatment re-engage in order to improve treatment outcome.

Study Type: Interventional

Study Design: Other, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study

We propose a 5-year Stage I behavioral therapy development study to: 1) prospectively evaluate risk factors for premature drop-out from outpatient treatment; 2) develop and test a manual of single session phone-and office-based interventions to re-engage these individual in treatment.

Intervention(s) in this Clinical Trial

• Behavioral: brief (behavioral therapy)

Primary Measures

• retention into outpatient treatment

Secondary Measures

• substance abuse
• psychiatric symptons

Inclusion Criteria:

• admission to outpatient treatment

Exclusion Criteria:

• need for hospitalization

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 65 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Overall Clinical Trial Officials and Contacts

Sam Ball, PhD Principal Investigator Yale School of Medicine  

Overall Contact: Rebekka Palmer, PhD 203-781-2777 rebekka.palmer@yale.edu

Information obtained from ClinicalTrials.gov on October 15, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00350571

Study ID Number: 101010101

ClinicalTrials.gov Identifier: NCT00350571

Health Authority: United States: Federal Government